Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the protein C/protein S anticoagulation system

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 6, 2006, Pages 453-458

  Tsuda, Tomohide ^a,b   Yoshimura, Hajime ^a   Hamasaki, Naotaka ^b  

^a SHINO TEST CORPORATION   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anticoagulation; Blood coagulation regulatory system; Liposome; Lysophosphatidylcholine; Phosphatidylcholine; Phosphatidylethanolamine; Phosphatidylserine; Phospholipase A2; Phospholipid; Protein C; Protein S; Thromboxane A2

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; LIPOSOME; LYSOPHOSPHATIDYLCHOLINE; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; PROCOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CELL MEMBRANE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ASSAY;

ANIMALS; CALMODULIN; CATTLE; FACTOR V; HEMOSTASIS; HUMANS; LIPOSOMES; LYSOPHOSPHATIDYLCHOLINES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; PROTEIN C; PROTEIN S;

EID: 33747176592     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000240917.71144.7b     Document Type: Article

References (29)

1. Zwaal RF, Comfurius P, van Deenen LL. Membrane asymmetry and blood coagulation. Nature 1977; 268:358-360.
2. Rosing J, Tans G, Govers-Riemslag JW, Zwaal RF, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255:274-283.
3. Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256:3433-3442.
4. Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122:429-436.
5. Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736:57-66.
6. Bach R, Gentry R, Nemerson Y, Esmon NL. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25:4007-4020.
7. Dachary-Prigent J, Toti F, Satta N, Pasquet JM, Uzan A, Freyssinet JM. Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin Thromb Hemost 1996; 22:157-164.
8. Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269:816-819.
9. Smirnov MD, Ford DA, Esmon CT, Esmon NL. The effect of membrane composition on the hemostatic balance. Biochemistry 1999; 38:3591-3598.
10. Norstrøm EA, Steen M, Tran S, Dahlbäck B. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. J Biol Chem 2003; 278:24904-24911.
11. Zwaal RF. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta 1978; 515:163-205.
12. Verkleij AJ, Zwaal RF, Roelofsen B, Comfurius P, Kastelijn D, van Deenen LL. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta 1973; 323:178-193.
13. Schroit AJ, Zwaal RF. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1991; 1071:313-329.
14. Devaux PF. Static and dynamic lipid asymmetry in cell membranes. Biochemistry 1991; 30:1163-1173.
15. Verkleij AJ, Post JA. Membrane phospholipid asymmetry and signal transduction. J Membr Biol 2000; 178:1-10.
16. Roelofsen B, van Deenen LL. Lipid requirement of membrane-bound ATPase. Studies on human erythrocyte ghosts. Eur J Biochem 1973; 40:245-257.
17. Rubalcava B, Rodbell M. The role of acidic phospholipids in glucagon action on rat liver adenylate cyclase. J Biol Chem 1973; 248:3831-3837.
18. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-2216.
19. Chimini G, Chavrier P. Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2000; 2:E191-E196.
20. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002; 417:182-187.
21. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89:2429-2442.
22. Zwaal RF. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta 1978; 515:163-205.
23. Bills TK, Smith JB, Silver MJ. Selective release of arachidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest 1977; 60:1-6.
24. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 1975; 72:2994-2998.
25. Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem 1988; 263:14884-14890.
26. Bakker HM, Tans G, Janssen-Claessen T, Thomassen MC, Hemker HC, Griffin JH, Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem 1992; 208:171-178.
27. Faioni EM, Valsecchi C, Palla A, Taioli E, Razzari C, Mannucci PM. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost 1997; 78:1343-1346.
28. Tsuda H, Hattori S, Tanabe S, Iida H, Nakahara M, Nishioka S, et al. Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality. Ann Clin Biochem 1999; 36:423-432.
29. Shen MC, Lin JS, Tsay W. Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res 2000; 99:447-452.